We are live on
!
Find out more
DMK
David M. Knott Portfolio holdings
AUM
$275M
Turnover
23.21%
1-Year Est. Return
59.23%
This Fund
S&P 500
This Quarter
Est. Return
+6.72%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
–
AUM
$281M
AUM Growth
+$47.6M
(+20%)
Cap. Flow
+$23.4M
Cap. Flow
% of AUM
8.3%
Top 10 Holdings %
Top 10 Hldgs %
45.9%
Holding
164
New
35
Increased
26
Reduced
12
Closed
17
Avg Time Held Equity + Options
2.4
years
Top 10 Avg Time Held Equity + Options
2
years
Top 20 Avg Time Held Equity + Options
1.7
years
Avg Time Held Equity only
2.4
years
Top 10 Avg Time Held Equity only
2
years
Top 20 Avg Time Held Equity only
1.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coliseum Acquisition Corp. Unit
MITAU
|
+$14.7M |
| 2 |
PSTH
Pershing Square Tontine Holdings, Ltd.
PSTH
|
+$6.6M |
| 3 |
FAZE
FaZe Holdings Inc. Common Stock
FAZE
|
+$5.13M |
| 4 |
Twelve Seas Investment Company II Class A Common Stock
TWLV
|
+$4.99M |
| 5 |
GLHA
Glass Houses Acquisition Corp. Class A common stock
GLHA
|
+$4.83M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 27.9% |
| 2 | Healthcare | 23.27% |
| 3 | Miscellaneous | 14.09% |
| 4 | Materials | 10.3% |
| 5 | Communication Services | 8.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
DELISTED
Priveterra Acquisition Corp. II Warrant to purchase Class A common stock
PMGMW
| $1.15M | 0.41% |
100,000
| – | – |
2021 Q1
1 quarter
|
|
52
Gilead Sciences
GILD
$194B
| $1.07M | 0.38% |
15,481
-35,461
| -70% | -$2.37M |
2020 Q3
3 quarters
|
|
53
Immunovant
IMVT
$5.52B
| $1.03M | 0.37% |
97,294
+63,194
| +185% | +$882K |
2021 Q1
1 quarter
|
|
54
Johnson & Johnson
JNJ
$616B
| $1M | 0.36% |
6,080
| – | – |
2013 Q2
32 quarters
|
|
55
Mondelez International
MDLZ
$81.6B
| $994K | 0.35% |
15,900
| – | – |
2013 Q2
32 quarters
|
|
56
Verizon
VZ
$186B
| $992K | 0.35% |
17,711
| – | – |
2014 Q2
28 quarters
|
|
|
QTEK
57
DELISTED
QualTek Services Inc. Class A Common Stock
QTEK
| $987K | 0.35% |
+100,000
| New | +$981K |
2021 Q2
0 quarters
|
|
58
Ryman Hospitality Properties
RHP
$8.69B
| $980K | 0.35% |
12,400
| – | – |
2013 Q2
32 quarters
|
|
|
CAP.WS
59
DELISTED
Capitol Investment Corp. V Warrants, each whole warrant exercisable for one share of Class A common
CAP.WS
| $958K | 0.34% |
83,333
| – | – |
2021 Q1
1 quarter
|
|
60
DuPont de Nemours
DD
$17.6B
| $938K | 0.33% |
9,654
| – | – |
2015 Q1
25 quarters
|
|
61
AbbVie
ABBV
$504B
| $901K | 0.32% |
8,000
-16,769
| -68% | -$1.89M |
2015 Q2
24 quarters
|
|
62
DELISTED
Cidara Therapeutics
CDTX
| $839K | 0.3% |
20,765
| – | – |
2019 Q2
8 quarters
|
|
|
LOKM.WS
63
DELISTED
Live Oak Mobility Acquisition Corp. Warrants, exercisable for one share of Class A common stock at an exercise price of $11.50 per share
LOKM.WS
| $828K | 0.29% |
+72,030
| New | +$97.4K |
2021 Q2
0 quarters
|
|
64
Canadian Natural Resources
CNQ
$111B
| $808K | 0.29% |
45,506
| – | – |
2017 Q2
16 quarters
|
|
65
Kimberly-Clark
KMB
$35.1B
| $803K | 0.29% |
6,000
| – | – |
2017 Q3
15 quarters
|
|
66
DELISTED
Colombier Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant
CLBR.U
| $794K | 0.28% |
+80,000
| New | +$793K |
2021 Q2
0 quarters
|
|
67
Dow Inc
DOW
$21.6B
| $767K | 0.27% |
12,118
| – | – |
2019 Q2
8 quarters
|
|
68
Coca-Cola
KO
$404B
| $725K | 0.26% |
13,400
| – | – |
2013 Q2
32 quarters
|
|
|
FAZEW
69
DELISTED
FaZe Holdings Inc. Warrant
FAZEW
| $678K | 0.24% |
+58,986
| New | +$59.8K |
2021 Q2
0 quarters
|
|
70
Butterfly Network
BFLY
$1.93B
| $663K | 0.24% |
45,760
+27,380
| +149% | +$370K |
2020 Q4
2 quarters
|
|
|
AGAC
71
DELISTED
African Gold Acquisition Corp
AGAC
| $657K | 0.23% |
+68,000
| New | +$657K |
2021 Q2
0 quarters
|
|
72
Innoviva
INVA
$1.5B
| $641K | 0.23% |
+47,798
| New | +$598K |
2021 Q2
0 quarters
|
|
73
IBM
IBM
$219B
| $628K | 0.22% |
4,481
| – | – |
2015 Q1
25 quarters
|
|
|
LGV
74
DELISTED
Longview Acquisition Corp. II
LGV
| $626K | 0.22% |
+63,900
| New | +$628K |
2021 Q2
0 quarters
|
|
75
AT&T
T
$161B
| $577K | 0.21% |
26,546
| – | – |
2014 Q2
28 quarters
|
|
Similar funds
FA
KCP
HCIA
ISG
TPCM
DCM
MCL
DVC
David M. Knott's Q2 2021 Portfolio in Review
As of Q2 2021, David M. Knott held 164 positions worth $281M, up 20% from $234M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
David M. Knott deployed $23.4M of net new capital in Q2 2021, opening 35 new positions and adding to 26 existing holdings. Its largest new stake was Coliseum Acquisition Corp. Unit: 1,485,000 shares worth $14.7M.
By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 23% a quarter earlier, followed by Healthcare and Miscellaneous.
On the sell side, the largest reduction was Gilead Sciences, an estimated $2.37M trimmed.
- David M. Knott's largest Q2 2021 buy was Coliseum Acquisition Corp. Unit: 1,485,000 shares worth $14.7M.
- David M. Knott added most to Calumet Specialty Products in Q2 2021, an estimated $1.9M increase.
- David M. Knott's biggest Q2 2021 reduction was Gilead Sciences, cutting an estimated $2.37M.
- David M. Knott fully exited African Gold Acquisition Corp Units in Q2 2021, selling an estimated $6.11M.
- David M. Knott's ten largest holdings make up 46% of its $281M portfolio in Q2 2021.
- David M. Knott opened 35 new positions and closed 17 in Q2 2021.
- David M. Knott's portfolio value rose 20% quarter-over-quarter to $281M.
Based on David M. Knott's 13F filing for Q2 2021, filed 13 Aug 2021.